Replay
Toggle
Menu
Platforms
Team
Building the next generation of genomic medicines
gene therapy
01.
Deliver 150kb DNA with HSV
Deliver 150kb DNA with HSV
In Vivo
Ex Vivo
Write and deliver big genes, genomic genes, or multiple genes
Complex regulatory elements
Address polygenic medicine
HSV Technology
Deliver DNA to autologous, allogeneic, and iPSC-derived cell therapies
Write and install large constructs to replace multiplex editing
Potential to multiplex CARs and TCRs
01 / 02
About us
Authoring the next generation of genomic medicines leveraging high payload HSV
Meet the team
Latest news
All news
Defining the Rules of Biology in the Age of Genome Writing
↳
GEN Biotechnology
20.12.2023
– MEDIA
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases
Read More
21.11.2022
– NEWS
Under hub-and-spoke biotech, serial founders launch new startup hoping to make gene therapies for the eye
↳
endpts.com
31.10.2022
– MEDIA
Replay launches its first HSV gene therapy company, Eudora, focused on retinal eye disease
Read More
31.10.2022
– NEWS
Join Replay
Help us to author the future of genomic medicine
Open positions